Migration Health is a regional newsletter highlighting how IOM and partners are making a difference to the lives of migrants and mobile populations across Africa and the Middle East. Packed with news features, interviews, photo galleries and IOM’s latest research, the newsletter underpins the Migration Health Division's core mandate to promote and deliver evidence-informed health policies and programmes which are beneficial, accessible, and equitable for migrants, mobile populations, and the communities in which they live, or transit.
The Migration for development in Africa (MIDA) initiative links the skills and expertise in the diaspora to the development of home countries. The MIDA Ghana Health project aims to build a bridge between available resources of the Ghanaian diaspora and needs, opportunities and policies in the health sector in Ghana. The main purpose of the project is to facilitate the temporary return to Ghana of Ghanaian health professionals from the diaspora residing in the Netherlands, United Kingdom, Germany and other EU countries for the benefit of local health institutions.
The aim of the study was to generate data on HIV and mobility to inform strategic decisions on HIV programming for Female Sex Workers (FSWs). Specific objectives of the study were to: (a) understand characteristics of the FSWs operating along the Tema‐Paga transport corridor; (b) understand mobility characteristics; (c) understand HIV vulnerability similarities and differences between roamers and seaters; and (d) identify HIV vulnerability (risk) factors.
The project refers to the health assessment of Australian-bound movements of visa classes 200 to 204.
The goals of this project are to guarantee, through appropriate medical screening planning, monitoring and support, that a number of eligible refugees consistent with the annual admission quota undergo the medical examination process within the duly timeframe. The project also aims to improve the quality of the medical clearance process through analysis, processing and dissemination of data included in OF 157 forms, enhanced follow-up of medical cases, reduced prevalence of untreated malaria and intestinal parasitosis.
As of April 1, 2017, the IRCC introduces a new reimbursement scheme for health assessment of Canada-bound refugees as a part of Interim Federal Health Program (IFHP), which until now has been providing temporary coverage of health care benefits to refugees in Canada.
At the request of the Government of the United Kingdom, IOM implements the Tuberculosis (TB) Detection Programme for visa applicants who intend to stay in the UK for a period of 6 months or longer. The main purpose of the programme is to address public health concerns regarding the spread of infectious tuberculosis in the UK by preventing the entry of people suffering from active TB until they have been successfully treated, as well as to facilitate access to diagnostics and referrals for treatment in the migrants’ countries of origin.
At the request of the Government of the United States of America, IOM carries out migration health assessment, vaccination and DNA sample collection services to self-payer visa applicants referred by local US Embassies, in accordance with the US government’s technical instructions.
At the request of the Government of New Zealand, IOM is carrying out migration health assessment and DNA sample collection services for immigration self-payer applicants referred by the local New Zealand High Commissions.
At the request of governments and entities other than the Governments of Australia, Canada, New Zealand, United Kingdom and United States, IOM carries out migration health assessment, DNA sample collection, age assessment, and pre-departure medical assessment services for refugees, returnees, students and immigration self-payer applicants referred by various governments and entities, such as UNHCR.